Please use this identifier to cite or link to this item:
Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection
Zhang, B
Liu, S
Tan, T
Huang, W
Dong, Y
Chen, L
Chen, Q
Zhang, L
Zhong, Q
Zhang, X
Zou, Y
Zhang, S
Acceso Abierto
As of March 24, 2020, novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been responsible for 379,661 infection cases with 16,428 deaths globally and the number is still increasing rapidly. Herein, we presented four critically ill patients with SARS-CoV-2 infection who received supportive care and convalescent plasma. Although all the four patients (including a pregnant woman) recovered from SARS-CoV-2 infection eventually, randomized trials are needed to eliminate the effect of other treatments and investigate the safety and efficacy of convalescent plasma therapy.
Chest (American College of Chest Physicians)
Appears in Collections:Artículos científicos

Upload archives

File SizeFormat 
104691.pdf294 kBAdobe PDFView/Open